Drug Topics
AUGUST 4, 2023
A 510(k) clearance, or a Premarket Notification, requires device manufacturers to notify the FDA at least 90 days ahead of registration with their intent to market a medical device.
Pharmacy Times
AUGUST 4, 2023
Compared to the BNT162b2 vaccine, the mRNA-1273 vaccine was associated with a lower risk of adverse events, which investigators speculate was due to interrelated safety and efficacy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 4, 2023
Nearly 25% of people “have vitamin D blood levels that are too low or inadequate for bone and overall health,” according to the NIH.
Pharmacy Times
AUGUST 4, 2023
CDC Advisory Committee on Immunization Practices voted 10 to 0 to recommend the routine use of nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
AUGUST 4, 2023
A study found that although the number of patients receiving a controller medication increased after their first exacerbation, the percentage given controller medications remained below 50% among the overall population.
Pharmacy Times
AUGUST 4, 2023
The findings suggest that cigarette smoking is an independent predictor for the expansion of hematoma, although smoking status does not cause a difference in mortality.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 4, 2023
Black adults, who have a higher likelihood of suffering from stroke at a young age, benefitted from blood pressure control and increased physical activity.
Fierce Healthcare
AUGUST 4, 2023
A silent and grossly underserved epidemic of loneliness is affecting 60% of all America | Numerous experts have called attention to our loneliness epidemic, describing its negative health impact as similar to “smoking 15 cigarettes a day.
Pharmacy Times
AUGUST 4, 2023
Notably, patients with transthyretin cardiac amyloidosis had higher rates of heart failure hospitalizations, including patients treated with tafamidis.
The Checkup by Singlecare
AUGUST 4, 2023
When you experience symptoms of allergies, hay fever, or the common cold, all you want is a solution—fast. Benadryl quickly relieves symptoms of red, itchy, watery eyes, sneezing, runny nose, cough, and an itchy throat. For some people, it can help manage symptoms of insomnia, Parkinson’s disease, or motion sickness. But before seeking relief from Benadryl, you should know it does have certain drug interactions.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 4, 2023
Specialty pharmacists play an important role in dispensing PCSK9 inhibitors and serve as a valuable source of assistance and education for patients.
Fierce Healthcare
AUGUST 4, 2023
State officials are urging members of the Oregon Health Plan to monitor their credit accounts as personal data on nearly 1.7 members was exposed as part of a massive data breach into a contractor.< | State officials are urging members of the Oregon Health Plan to monitor their credit accounts as personal data on nearly 1.7 members was exposed as part of a massive data breach into a contractor.
Pharmacy Times
AUGUST 4, 2023
Dr Haumschild drives a discussion around what pharmacies and health care systems can expect from RSV infections in adult patient populations.
Drug Store News
AUGUST 4, 2023
The donation will help provide more than 9,000 bags of food to be distributed to preschool and elementary children, designed to replace food that those kids would normally have received at school.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
AUGUST 4, 2023
Electronic health record utilization and financial considerations for RSV vaccines in adults are overviewed by Drs Madison and Welch.
STAT
AUGUST 4, 2023
Early-stage cancer diagnoses decreased by nearly 20% in the first year of the Covid-19 pandemic. A new study published in Lancet Oncology emphasizes how, because of disruptions in care, patients were more likely to get diagnosed with deadly metastatic disease — across nearly all cancer types. This study is the most comprehensive analysis of cancer diagnoses during the pandemic, using a nationwide registry that captures over 70% of all cancers in the United States.
Pharmacy Times
AUGUST 4, 2023
Nikhil Palekar discusses the FDA approval of lecanemab-irmb (Leqembi, Eisai) and what this means for those who have Alzheimer Disease.
STAT
AUGUST 4, 2023
The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year, a cut that’s more than eight times larger than the one proposed in April. The Centers for Medicare and Medicaid Services originally said it would cut payments meant to help safety net hospitals by $115 million in 2024. In the final rule released this week, however, that cut grew to $957 million.
Pharmacy Times
AUGUST 4, 2023
Drs Haumschild, Anderson, and Hinojosa provide their closing thoughts regarding treatment considerations for patients with RRMM.
Fierce Healthcare
AUGUST 4, 2023
LGBTQ+ adults are less likely than cisgender, heterosexual adults to have had health screenings in the past year and are more likely to have skipped care, a new survey has found. | In the past year, 25% of LGBTQ+ adults did not have any health screenings, compared to 20% of cisgender, heterosexual adults.
Pharmacy Times
AUGUST 4, 2023
Wastewater surveillance could be the most consistent way to measure COVID-19 across US counties, a recent study indicates.
STAT
AUGUST 4, 2023
The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market. The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically.
Pharmacy Times
AUGUST 4, 2023
Social jet lag could create adverse health impacts that a 90-minute difference in the mid-point of sleep can improve.
STAT
AUGUST 4, 2023
“All of your medical and surgical expenses will be paid by your recipient’s insurance,” the nurse coordinator at the Mayo Clinic told me. Naïve, I nodded into the phone at this reassurance. I had already worked with her to have several vials of my blood shipped from my home in Kansas City to Mayo in Rochester, Minnesota, all at no cost to me.
Drug Store News
AUGUST 4, 2023
Walgreens Boots Alliance sold shares of AmerisourceBergen common stock through a registered public offering of approximately $1.6 billion. AmerisourceBergen also announced a registered public offering of 10.5 million shares of common stock.
Fierce Pharma
AUGUST 4, 2023
In a bid to thwart shortages of critical hospital drugs, Pfizer is relegating certain products made in Rocky Mount, North Carolina, to its emergency ordering list. | In a bid to thwart shortages of critical drugs, Pfizer is relegating certain products made in Rocky Mount, North Carolina, to its emergency ordering list. The move comes after a tornado hit the company's injectables facility late last month, creating questions about potential supply disruptions.
STAT
AUGUST 4, 2023
Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text. Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. In six months, he won’t be able to move at all.
Fierce Pharma
AUGUST 4, 2023
And the hits just keep on coming for Galapagos. | Based on the results of a phase 3 study, Galapagos has decided not to submit a Marketing Authorization Application in Europe for Jyseleca (filgotinib) in Crohn’s disease. The company also will not proceed with its application for filgotinib in ulcerative colitis in Switzerland. Galapagos revealed the moves in reporting its first-half earnings.
Fierce Healthcare
AUGUST 4, 2023
Optum Rx has a new leader at the helm. | Optum Rx has a new leader at the helm. Patrick Conway, M.D., will step into the role of CEO of the pharmacy benefit management giant.
Fierce Pharma
AUGUST 4, 2023
In January, when Amgen launched the first biosimilar to compete with AbbVie’s Humira in the U.S., the company looked forward to six months of exclusivity in competing one-on-one against the immunol | When Amgen launched the first biosimilar to compete with AbbVie’s Humira in the U.S., the company looked forward to six months of exclusivity in competing one-on-one against the immunology powerhouse.
STAT
AUGUST 4, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Fierce Pharma
AUGUST 4, 2023
In their ongoing RET inhibitor rivalry, Eli Lilly is pulling further ahead of Blueprint Medicines, even as the latter company is being abandoned by Roche. | In their ongoing RET inhibitor rivalry, Eli Lilly is pulling further ahead of Blueprint Medicines, even as the latter company is being abandoned by Roche.
STAT
AUGUST 4, 2023
The organization that runs ProMed , an early warning system on disease outbreaks, defended its plans to charge a subscription for its service on Friday, calling it “the only viable path forward” given the resources required to run it. In a lengthy statement , the head of the International Society for Infectious Diseases (ISID) apologized for “any confusion and distress” caused by communication of the group’s plans.
Pharmacy Times
AUGUST 4, 2023
Navigating treatment toxicities is paramount to achieving treatment goals in MM management.
Expert insights. Personalized for you.
185 
Let's personalize your content